These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9130694)

  • 1. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
    Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
    EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.
    Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA
    Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
    Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
    Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
    Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
    J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
    Hewat EA; Blaas D
    EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
    Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
    J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
    Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
    Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
    Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
    J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge.
    Thouvenin E; Laurent S; Madelaine MF; Rasschaert D; Vautherot JF; Hewat EA
    J Mol Biol; 1997 Jul; 270(2):238-46. PubMed ID: 9236125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and dynamics of the GH loop of the foot-and-mouth disease virus capsid.
    Azuma H; Yoneda S
    J Mol Graph Model; 2009 Oct; 28(3):278-86. PubMed ID: 19734079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
    Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
    Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
    Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
    J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
    Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy.
    Prasad BV; Burns JW; Marietta E; Estes MK; Chiu W
    Nature; 1990 Feb; 343(6257):476-9. PubMed ID: 2153941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
    Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
    Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
    Schulze-Gahmen U; Rini JM; Wilson IA
    J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
    Lok SM; Kostyuchenko V; Nybakken GE; Holdaway HA; Battisti AJ; Sukupolvi-Petty S; Sedlak D; Fremont DH; Chipman PR; Roehrig JT; Diamond MS; Kuhn RJ; Rossmann MG
    Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
    Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
    Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.
    Verdaguer N; Sevilla N; Valero ML; Stuart D; Brocchi E; Andreu D; Giralt E; Domingo E; Mateu MG; Fita I
    J Virol; 1998 Jan; 72(1):739-48. PubMed ID: 9420281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.